IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Sahajanand Medical Technologies IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in Surat and caters to Healthcare sector. Avendus Capital , Hsbc Securities & Capital Markets Limited , Motilal Oswal Investment Advisors , Nuvama Wealth Management are the merchant bankers of Sahajanand Medical Technologies IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 25th July 2025.
Sahajanand Medical Technologies IPO posted revenues of ₹ 1,024.88 Cr. and PAT of ₹ 25.15 Cr. in FY25 on annualised basis.
Revenue:
₹ 1,024.88 Cr.
EBITDA Margin:
12.49
% 
Net Worth: ₹ 565.73 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: 0.97 times
Financial results of Sahajanand Medical Technologies IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY25 | FY24 | FY23 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 1094.90 | 970.58 | 911.63 | ||
| Net Worth | 565.73 | 540.01 | 553.30 | ||
| Total Debt | 224.96 | 175.27 | 132.81 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
1024.88 | 901.60 | 795.44 | ||
EBITDA
EBITDA on annualised basis |
128.02 | 110.04 | 110.77 | ||
PAT
PAT on annualised basis |
25.15 | -7.35 | 11.93 | ||
Sahajanand Medical Technologies IPO PAT Margin is 2.45 % , ROCE (Return on Capital Employed) is 10.37 % as per latest financial. The below table shows Sahajanand Medical Technologies IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY25 | FY24 | FY23 |
|---|---|---|---|
| EBITDA Margin (%) | 12.49 | 12.20 | 13.93 |
| PAT Margin (%) | 2.45 | -0.82 | 1.50 |
| EPS (₹) | 2.09 | -1.31 | 0.84 |
| ROE (%) | 4.45 | -1.36 | 2.16 |
| ROCE (%) | 10.37 | 8.05 | 10.54 |
| ROA (%) | 2.30 | -0.76 | 1.31 |
| Debt to Equity | 0.40 | 0.32 | 0.24 |
The market Capitalisation of Sahajanand Medical Technologies IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Sahajanand Medical Technologies IPO prospectus highlights an Return on Equity (ROE) of 4.45 % , Return on Assets (ROA) of 2.30 %, and an EBITDA Margin of 12.49 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Sahajanand Medical Technologies IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Sahajanand Medical Technologies IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Sahajanand Medical Technologies IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Sahajanand Medical Technologies IPO reported revenue of ₹ 1024.88 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Sahajanand Medical Technologies IPO provide insights into sales growth, market demand, and business scalability.
Sahajanand Medical Technologies recorded an EBITDA of ₹ 128.02 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Sahajanand Medical Technologies Profit After Tax (PAT) is ₹ 25.15 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 1,024.88 Cr.
EBITDA Margin:
12.49
%
Net Worth: ₹ 565.73 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA:
[●]
Sahajanand Medical Technologies operates in Healthcare and Developer Of Class III And Class C/D Medical Devices, With A Strong Focus On Vascular And Structural Heart Interventions.. The Issue is listed on BSE,NSE in Aug, 2025. Sahajanand Medical Technologies IPO size was with Issue price of .
Merchant Banker(s) of Sahajanand Medical Technologies IPO: Avendus Capital Private Limited , Hsbc Securities & Capital Markets Private limited , Motilal Oswal Investment Advisors Limited , Nuvama Wealth Management Limited
Sahajanand Medical Technologies IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Sahajanand Medical Technologies IPO listed at a listing price of against the offer price of .
The current market price of Sahajanand Medical Technologies is .
Why Us?
